Veru's COVID-19 drug hopeful scrapes efficacy hurdle, but questions remain

Retrieved on: 2021-02-09 15:00:00

Tags for this article:

Click the tags to see associated articles and topics

Veru's COVID-19 drug hopeful scrapes efficacy hurdle, but questions remain. View article details on hiswai:

Excerpt

Little-known Miami biotech Veru saw its shares jump this week after reporting seemingly positive data from a small phase 2 in COVID-19 patients.

Article found on: www.fiercebiotech.com